Electrophysiological manifestations in adults with HIV/AIDS submitted and not submitted to antiretroviral therapy;Manifestações eletrofisiológicas em adultos com HIV/AIDS submetidos e não-submetidos à terapia anti-retroviral

Pro-Fono

Volumn 22, Issue 2, 2010, Pages 107-112

  Matas, Carla Gentile ^a   Silva, Sara Manami ^b   de Almeida Marcon, Bruna ^b   Gonçalves, Isabela Crivellaro ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiretroviral therapy; Auditory; Evoked potentials; Hearing; Highly active; HIV

Indexed keywords

EID: 77955294984     PISSN: 01045687     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-56872010000200007     Document Type: Article

References (26)

1. Montaner JSG, Hogg RS, ÓShaughnessy MV. Emerging international consensus for use of anti-retroviral therapy. Lancet. 1997;349:1042.
2. Roland Jr JT, Alexiades G, Jackman AH, Hillman D, Shapiro W. Cochlear Implantation in Human Immunodeficiency Virus -Infected Patients. Otol & Neurotol. 2003;24(6):892-5.
3. Junqueira CAO, Colafêmina JF. Investigação da estabilidade inter e intra-examinador na identificação do P300 auditivo: análise de erros. Rev Bras Otorrinolaringol. 2002;68(4):468-78.
4. Reyes-Contreras L, Silva-Rojas A, Ysunza-Rivera A, Jimenez-Ruiz G, Berruecos-Villalobos P, Romo-Gutierrez G. Brainstem auditory evoked response in HIV-infected patients with and without AIDS. Arch Med Res. 2002; 33(1):25-8.
5. Castello E, Baroni N, Pallestrini E. Neurotological auditory brain stem response findings in human immunodeficiency virus-positive patients without neurologic manifestation. Ann Oto Rhinol Laryngol. 1998; 107(12):1054-60.
6. Goodin DS, Aminoff MJ, Chernoff DN, Hollander H. Long latency event-related potentials in patients infected with human immunodeficiency virus. Ann Neurol. 1990; 27(4):414-9.
7. Fein G, Biggins CA, MacKay S. Delayed latency of the event-related brain potential P3A component in HIV disease. Progressive effects with increasing cognitive impairment. Arch Neurol. 1996;53(8):715-6.
8. Ollo C, Johnson R, Grafman J. Signs of cognitive change in HIV disease: an event-related brain potential study. Neurology. 1991;41:209-15.
9. Serafini G, Stagni G, Chiarella G, Brizi S, Simoncelli C. ABR and HIV-induced impairment of the central nervous system. Rev Laryngol Otol Rhinol. 1998;119(2):87-90.
10. Jasper HA. The ten-twenty system of the International Federation. Electroencephalogr Clin Neurophysiol. 1958; 10:371-5.
11. Musiek FE, Lee WW. Potenciais auditivos de média e longa latência. In: Musiek FE, Rintelmann WF, editores. Perspectivas atuais em avaliação auditiva. Barueri: Manole; 2001. p. 239-56.
12. McPherson DL. Late potentials of the auditory system. San Diego: Singular Pub Group; 1996.
13. Mata Castro N, Yebra Bango M, Tutor de Ureta P, Villarreal Garcia-Lomas M, Garcia Lopez F. Hearing loss and human immunodeficiency virus infection. Study of 30 patients. Rev Clin Esp. 2000;200(5):271-4.
14. Bankaitis AE, Christensen LA, Murphy G, Morehouse CR. HIV/AIDS and auditory evoked potentials. Seminars in Hearing. 1998;19(2):177-93.
15. Pierelli F, Garrubba C, Tilia G, Parisi L, Fattaposta F, Pozzessere G, Soldati G, Stanzione P, D'Offizi G, Mezzaroma I. Multimodal evoked potentials in HIV-1 seropositive patients: relationship between the immune impairment and the neurophysiological function. Acta Neurol Scand. 1996; 93(4):226-71.
16. Reyes A, Ysunza A, Silva A, Jiménez G, Berruecos P, Romo G. Potenciales provocados auditivos de latencia corta en pacientes infectados por virus de inmunodeficiencia humana. Resultados preliminares. An otorrinolaringol mex. 1999;44(1):3-7.
17. Somma-Mauvais H, Farnarier G. Evoked potentials in HIV infection. Neurophysiol Clin. 1992;22(5):369-84.
18. Gold S, Tami TA. Otolaryngological manifestations of HIV/AIDS. Seminars in Hearing. 1998;19(2):165-75.
19. Prasad HKC, Bhojwani KM, Shenoy V, Prasad SC. HIV manifestation in otolaryngology. Am J Otolaryngol -Head Neck Med Surg. 2006;179-85.
20. Soucek S, Michaels L. The ear in the acquired immunodeficiency syndrome: II. Clinical and audiologic investigation. Am J Otol. 1996;17(1):35-9.
21. Picton TW, Hillyard SA, Krausz HI, Galambos R. Human auditory evoked potentials. I. Evaluation of Components. Electroencephalogr Clin Neurophysiol. 1974;36:179-90.
22. Anders K, Guerra WF, Tomiyasu U, Rosen RJ, Telling S. The neuropathology of AIDS. UCLA experience and review. Am J Pathol. 1986;124:537-58.
23. Polich J, Ilan A, Poceta JS, Mitler MM, Darko DF. Neuroelectric assessment of HIV: EEG, ERP, and viral load. Int J Psychophysiol. 2000;38(1):97-108.
24. Tartar JL, Sheehan CM, Nash AJ, Starratt C, Puga A, Widmayer S. ERPs differ from neurometric tests in assessing HIV-associated cognitive deficit. Neuroreport. 2004;15(10): 1675-8.
25. Smith T, Jakobsen J, Gaub J, Helweg-Larsen S, Trojaborg W. Clinical and electrophysiological studies of human immunodeficiency virus -soropositive men without AIDS. Ann Neurol. 1988;23:295-7.
26. Vieira ABC, Greco DB, Teófilo MMM, Gonçalves DU. Manifestações otoneurológicas associadas à terapia anti-retroviral. Rev Soc Bras Med Tropical. 2008;41(1):65-9.